Background
Acetaminophen is the most commonly implicated drug in cases of acute liver failure (ALF) predominantly due to its widespread availability [
1‐
5]. Excluding combination preparations, approximately 1.5 billion tablets are sold annually in Canada[
6]. Recent data from the US ALF Study Group identified acetaminophen as the etiology in approximately 50% of cases[
2,
3]. Acetaminophen overdose typically has a good prognosis, even if hepatic failure has developed. Less than 5% of patients who take toxic quantities of acetaminophen (approximately 150 mg/kg body weight) develop acute liver toxicity [
7]. and survival without transplantation for those who develop encephalopathy (~65%) exceeds that for most other forms of ALF [
2‐
4]. Nevertheless, nearly one-third of those developing encephalopathy will die and 8% require transplantation [
2‐
4]. The cost of treating patients with acetaminophen overdose was estimated at over $87 million annually in the US in 1995;[
8] this is likely a conservative estimate in light of current health care costs.
Due to these important public health implications, a wealth of literature has focused on the epidemiology of acetaminophen overdose [
9‐
19]. Most reports originate in the United Kingdom (UK) where legislation in 1998 limited the size of packets of acetaminophen to 16 tablets of 500 mg[
9,
10]. Although results are variable, most studies suggest a benefit of this legislation. In a systematic review examining the impact of these restrictions, Morgan
et al. reported a reduction in hospital admissions and liver transplants for acetaminophen overdose, but conflicting findings regarding the severity of poisonings, deaths, and over the counter sales following this legislation[
11].
Recently, Prior
et al. examined the epidemiology of acetaminophen overdose in Canada[
6]. Between 1995 and 2002, the annual hospitalization rate for acetaminophen overdose was 27 per 100,000 population. This rate did not change significantly after the lifting of restrictions limiting sales of acetaminophen (tablets > 325 mg or quantities > 24 tablets) to pharmacies only in 1999–2000[
6]. Unfortunately, this study did not describe the characteristics of patients with acetaminophen overdose, including sociodemographic factors. Studies have suggested that younger age and female gender increase the risk of acetaminophen overdose,[
12,
13] but Canadian data is lacking.
Therefore, we conducted a population-based study to examine risk factors for acetaminophen overdose in a large Canadian health region. We were particularly interested in the impact of Aboriginal race and low socioeconomic status on rates of acetaminophen overdose since a wealth of literature has demonstrated greater health disparities, including an increased risk of suicide, in Aboriginal [
14,
15] and lower income Canadians[
16,
17]. We also examined temporal trends in hospitalization rates for acetaminophen overdose, including both intentional and accidental ingestions. An understanding of the predisposing factors for acetaminophen overdose might permit targeting of preventive initiatives at high risk subgroups if a substantial need is uncovered by the epidemiologic analysis.
Discussion
In this population-based study, we examined trends in hospitalization rates for acetaminophen overdose in a large Canadian health region. Between 1995 and 2004, the adjusted annual hospitalization rate for acetaminophen overdose was 15.5 per 100,000 population. This rate is approximately one-fifth of that reported in the UK despite legislation limiting sales of acetaminophen in that country[
12,
27,
28]. Although the explanations for this discrepancy are beyond the scope of this study, differences in acetaminophen availability seem unlikely considering the relatively liberal sale of acetaminophen in Canada. Moreover, suicide rates are similar in the UK and Canada[
29,
30]. Presumably, this discrepancy reflects different methods of suicide in the two countries (eg. more frequent use of firearms, hanging, and suffocation in Canada versus poisoning in the UK)[
29,
30]. We also report a 41% decline in the annual rate of hospitalization between 1995 and 2004. This decline was more pronounced in females, younger patients (under 50 years), and for intentional overdoses. Our study is at odds with a recent Canadian epidemiologic investigation of acetaminophen overdose[
6]. In this analysis of Canada-wide hospital discharge data, Prior
et al. reported only a slight decrease (~10%) in hospitalization rates for acetaminophen overdose between 1995 and 2001 (vs. 30% in our study). The purpose of this study was to examine the impact of the lifting of place-of-sale restrictions in 1999 on rates of acetaminophen overdose. Provincial data for Alberta was aggregated with that of other provinces (Nova Scotia and Prince Edward Island) that did not have restrictions prior to this time point. Therefore, data specific to our health region or Alberta cannot be extracted from this report. Of pertinence is that overdose rates in our health region appear to differ from other regions, even within Alberta. For example, Colman
et al. reported much lower rates of emergency department visits for self-inflicted injuries in Calgary compared with Edmonton (the other major city in the province) during the same time period[
31]. This finding likely reflects differences in the underlying populations. Since low SES appears to be associated with acetaminophen overdose (see below), the relative prosperity of the CHR due to its high concentration of petroleum companies may account for the lower rates that we observed.
The majority of the data from other countries supports our observation. Although US data is limited, Nourjah
et al. reported a 10% decline in acetaminophen-related 'poison control calls' to centers involved in the Toxic Exposure Surveillance System between 1997 and 2001[
13]. Similarly, Turvill
et al. reported declines of 21% and 64% in all acetaminophen overdoses and severe overdoses, respectively, presenting to the Royal Free Hospital in London between 1995 and 2002[
28]. In Scotland, Bateman
et al. reported an increase in hospitalizations from 1990 to 1997 followed by an approximate 20% decrease between 1997 and 1999 (2000–2004 data was not reported)[
12]. Hughes
et al. also reported a fall in hospital admissions for acetaminophen overdose in Birmingham between 1995 and 1999[
32]. These reductions have been attributed to legislation limiting the sale of acetaminophen in the UK The fall in hospitalization rates in our region is somewhat surprising since efforts to reduce acetaminophen overdose, including package size restrictions, have not been undertaken. Colman
et al. actually reported an
increase in visits to emergency departments in Alberta for self-inflicted injuries during this time period (but trends in acetaminophen overdose were not reported)[
31]. In addition, Canadian suicide rates have remained stable during the past two decades[
29]. Presumably this conflicting data relates to shifting trends in methods of suicide[
29]. Huchcroft
et al. observed a decline in self-poisoning deaths in Canadian females, but an increase in suicides due to hanging, strangulation and suffocation in males[
33]. An alternative explanation is that thresholds for hospitalizing patients with acetaminophen overdose have become more stringent. Increasing demand for hospital beds and greater experience managing these patients are possible explanations. Because our data does not represent all incident cases, we cannot confirm these speculations.
Hospitalization rates for accidental acetaminophen overdose appeared to rise during the latter years of our study following an initial decline between 1995 and 2002. Such 'therapeutic misadventures' [
34,
35] occurred in 13% of our study population. This finding is in keeping with data from the US ALF Study Group reporting that a striking 50% of ALF cases due to acetaminophen were accidental[
2]. Based on this data, it has been estimated that approximately 500 ALF cases and 150 deaths attributable to unintentional overdoses occur annually in the US[
36]. Since accidental ingestions have been linked with a greater risk of hepatotoxicity, [
3,
37‐
39] our observation of a recent increase is of public health importance. Currently over 100 products containing sometimes large amounts of acetaminophen are available over-the-counter, and many patients (and physicians) are unaware of their acetaminophen content[
36]. The observed increase in hospitalization rate coincides with the availability of extended release acetaminophen preparations in Canada (since 1999); misinformation about the proper dosing of these formulations may have played a role. Our data emphasizes the necessity of educational initiatives regarding the safe use of acetaminophen and clear labeling of medications with their acetaminophen content so that this trend does not continue.
A major strength of our data is the examination of population-based, sociodemographic risk factors for acetaminophen overdose. As reported in other studies, females, especially those in their teenage years and twenties, are at greatest risk[
6,
12,
28,
32,
40‐
44]. Hospitalization rates are four to five-fold higher among individuals who require social assistance and status Aboriginals. High rates of suicidal behaviour have been reported in the Aboriginal communities of Canada and other countries,[
45,
46]. emphasizing the necessity of suicide prevention strategies in this population. Presumably sociodemographic factors contribute to this risk, but this could not be examined specifically due to coding methods among Aboriginals in our databases. The high rate of alcohol-related diagnoses in our study cohort (33%), particularly among status Aboriginals (64%), likely contributed to the risk of acetaminophen overdose in these subgroups[
47].
Another strength of our study is the use of population-based data from a large geographic region. Many prior studies have originated in referral centres, including liver transplant units, and are prone to selection bias[
2‐
5,
38]. For example, data from the US ALF Study Group suggests that the proportion of ALF cases due to acetaminophen overdose is on the rise[
2]. However, since denominator data is not available in this type of study due to the recruitment methods, population-based studies such as our own are necessary to truly appreciate trends in rates of acetaminophen overdose. Moreover, part of the explanation for the apparently increasing rates in this study (versus the
decrease that we observed) is that the proportion of ALF cases due to viral hepatitis has fallen presumably as a result of widespread vaccination. This shift in etiologies has likely led to an overemphasis of the importance of acetaminophen overdose in current data.
Our study has several limitations. First, the validity of coding suicidal intent in patients with acetaminophen overdose has not been validated. However, studies of other conditions have suggested that E-codes provide a reliable indication of suicidal intent[
48,
49]. For example, LeMier
et al. reported 95% agreement between E-codes obtained from administrative data and medical record review for defining suicidal intent in a variety of injuries including poisonings, falls, and firearm incidents. For poisonings specifically, agreement was 87%[
48]. In another study of adult subscribers to a health maintenance organization in California, medical record reviews confirmed that 86% of hospitalizations assigned "intentional" E-codes were suicide attempts[
49]. An additional limitation of our study is the reliance on discharge data to identify only hospitalized cases, which clearly underestimates the true incidence of acetaminophen overdose. Patients who didn't seek medical attention or weren't hospitalized would not have been captured by our search strategy. However, we have identified the most clinically relevant cases at the highest risk of adverse outcomes and consumption of health care resources.
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
Dr. Myers conceived the study idea, performed all statistical analyses, and drafted the manuscript. B. Li and A. Fong performed data extraction and revised the manuscript critically for important intellectual content. Drs. A. Shaheen and H. Quan assisted with statistical analysis and revised the manuscript critically for important intellectual content. All authors read and approved the final version of the manuscript. Dr. Myers is the guarantor of the study.